Nasser H. Hanna,Frances A. Shepherd,Frank V. Fossella,Jose R. Pereira,Filippo de Marinis,Joachim von Pawel,U. Gatzemeier,Thomas Chang Yao Tsao,Miklos Pless,Thomas Müller,Hong-Liang Lim,Christopher E. Desch,Klára Szondy,Radj Gervais,Shaharyar,Christian Manegold,Sofia Paul,Paolo Paoletti,Lawrence Einhorn,Paul A. Bunn
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology] 日期:2023-05-17卷期号:41 (15): 2682-2690被引量:162
To compare the efficacy and toxicity of pemetrexed versus docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with chemotherapy.